Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Industry sponsor intelligence

AbbVieClinical Pipeline.

Lead-sponsor view of AbbVie's indexed peptide studies, development phases, active programs, completed work and recent registry changes.

Total
4
Recruiting
0
Active
0
Completed
4
Results posted
4
Avg enrollment
240

Pipeline overview

Programs by phase and activity.

Velocity

AbbVie trials by start year

Study start year · indexed snapshot

2211020192019: 2 trials20202020: 0 trials20212021: 0 trials20222022: 1 trials20232023: 1 trials

Development

Trials by phase

Early Phase 10
Phase 10
Phase 21
Phase 33
Phase 40
ProductStudiesEarly / IPhase IIPhase IIIPhase IVActive
Linaclotide →401300

Active peptide trials

In motion now.

No studies in this snapshot.

Completed trials

Finished registry records.

Search sponsor records

All AbbVie studies.

This page groups studies where AbbVie is listed as the lead industry sponsor. Collaborator-only records are not included in the count.

4 matching studies

End of 4 results

Recent updates

Latest registry movement.

NCT05652205A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional ConstipationMay 14, 2026NCT04166058Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-CJan 6, 2026NCT05760313A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With LinaclotideJan 6, 2026NCT04026113Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)Nov 26, 2024